134 related articles for article (PubMed ID: 1324428)
1. Major growth reduction and minor decrease in mitochondrial enzyme activity in cultured human muscle cells after exposure to zidovudine.
Herzberg NH; Zorn I; Zwart R; Portegies P; Bolhuis PA
Muscle Nerve; 1992 Jun; 15(6):706-10. PubMed ID: 1324428
[TBL] [Abstract][Full Text] [Related]
2. Zidovudine causes early increases in mitochondrial ribonucleic acid abundance and induces ultrastructural changes in cultured mouse muscle cells.
d'Amati G; Lewis W
Lab Invest; 1994 Dec; 71(6):879-84. PubMed ID: 7528833
[TBL] [Abstract][Full Text] [Related]
3. Effects of short-term zidovudine exposure on mitochondrial DNA content and succinate dehydrogenase activity of rat skeletal muscle cells.
Kiyomoto BH; Tengan CH; Godinho RO
J Neurol Sci; 2008 May; 268(1-2):33-9. PubMed ID: 18045616
[TBL] [Abstract][Full Text] [Related]
4. Zidovudine myopathy: a distinctive disorder associated with mitochondrial dysfunction.
Mhiri C; Baudrimont M; Bonne G; Geny C; Degoul F; Marsac C; Roullet E; Gherardi R
Ann Neurol; 1991 Jun; 29(6):606-14. PubMed ID: 1892364
[TBL] [Abstract][Full Text] [Related]
5. Uridine supplementation antagonizes zidovudine-induced mitochondrial myopathy and hyperlactatemia in mice.
Lebrecht D; Deveaud C; Beauvoit B; Bonnet J; Kirschner J; Walker UA
Arthritis Rheum; 2008 Jan; 58(1):318-26. PubMed ID: 18163507
[TBL] [Abstract][Full Text] [Related]
6. Mitochondria in cultured human muscle cells depleted of mitochondrial DNA.
Herzberg NH; Middelkoop E; Adorf M; Dekker HL; Van Galen MJ; Van den Berg M; Bolhuis PA; Van den Bogert C
Eur J Cell Biol; 1993 Aug; 61(2):400-8. PubMed ID: 8223726
[TBL] [Abstract][Full Text] [Related]
7. Abnormal skeletal and cardiac muscle mitochondria induced by zidovudine (AZT) in human muscle in vitro and in an animal model.
Lamperth L; Dalakas MC; Dagani F; Anderson J; Ferrari R
Lab Invest; 1991 Dec; 65(6):742-51. PubMed ID: 1753716
[TBL] [Abstract][Full Text] [Related]
8. Zidovudine [AZT] myotoxicity: quantitative separation of AZT effects on proliferation and differentiation of muscle cells in vitro. Lack of myotoxicity potentiation by retrovirus.
Waclawik AJ; Vann J; Schmelz G; Szurek P; Lewandoski P; Brooks BR
Neurotoxicology; 1999 Feb; 20(1):49-56. PubMed ID: 10091858
[TBL] [Abstract][Full Text] [Related]
9. Expression of cytochrome c oxidase subunits encoded by mitochondrial or nuclear DNA in the muscle of patients with zidovudine myopathy.
Chariot P; Bonne G; Authier FJ; Marsac C; Gherardi R
J Neurol Sci; 1994 Sep; 125(2):190-3. PubMed ID: 7807166
[TBL] [Abstract][Full Text] [Related]
10. Effect of L-carnitine on the zidovudine-induced destruction of human myotubes. Part I: L-carnitine prevents the myotoxicity of AZT in vitro.
Semino-Mora MC; Leon-Monzon ME; Dalakas MC
Lab Invest; 1994 Jul; 71(1):102-12. PubMed ID: 7518879
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial (mt)DNA changes in tissue may not be reflected by depletion of mtDNA in peripheral blood mononuclear cells in HIV-infected patients.
Maagaard A; Holberg-Petersen M; Kollberg G; Oldfors A; Sandvik L; Bruun JN
Antivir Ther; 2006; 11(5):601-8. PubMed ID: 16964828
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial myopathy caused by long-term zidovudine therapy.
Dalakas MC; Illa I; Pezeshkpour GH; Laukaitis JP; Cohen B; Griffin JL
N Engl J Med; 1990 Apr; 322(16):1098-105. PubMed ID: 2320079
[TBL] [Abstract][Full Text] [Related]
13. Age-dependent respiratory function decline and DNA deletions in human muscle mitochondria.
Hsieh RH; Hou JH; Hsu HS; Wei YH
Biochem Mol Biol Int; 1994 Apr; 32(6):1009-22. PubMed ID: 8061617
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial encephalomyopathies: biochemical approach.
Dimauro S; Moraes CT; Shanske S; Lombes A; Nakase H; Mita S; Tritschler HJ; Bonilla E; Miranda AF; Schon EA
Rev Neurol (Paris); 1991; 147(6-7):443-9. PubMed ID: 1660180
[TBL] [Abstract][Full Text] [Related]
15. Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy.
Arnaudo E; Dalakas M; Shanske S; Moraes CT; DiMauro S; Schon EA
Lancet; 1991 Mar; 337(8740):508-10. PubMed ID: 1671889
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis in mitochondrial myopathies is linked to mitochondrial proliferation.
Auré K; Fayet G; Leroy JP; Lacène E; Romero NB; Lombès A
Brain; 2006 May; 129(Pt 5):1249-59. PubMed ID: 16537564
[TBL] [Abstract][Full Text] [Related]
17. Cellular and mitochondrial toxicity of zidovudine (AZT), didanosine (ddI) and zalcitabine (ddC) on cultured human muscle cells.
Benbrik E; Chariot P; Bonavaud S; Ammi-Saïd M; Frisdal E; Rey C; Gherardi R; Barlovatz-Meimon G
J Neurol Sci; 1997 Jul; 149(1):19-25. PubMed ID: 9168161
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of zidovudine-induced mitochondrial toxicity and myopathy.
Scruggs ER; Dirks Naylor AJ
Pharmacology; 2008; 82(2):83-8. PubMed ID: 18504416
[TBL] [Abstract][Full Text] [Related]
19. [Assessment of mitochondrial toxicity induced by zidovudine and adefovir dipivoxil in rats].
Zhu B; Zhu ZN; Wang JZ; Huang SM; Feng XM; Li AY; Yang DL; Wang BJ
Zhonghua Gan Zang Bing Za Zhi; 2012 Oct; 20(10):794-7. PubMed ID: 23207344
[TBL] [Abstract][Full Text] [Related]
20. Nuclear and mitochondrial changes of muscle fibers in AIDS after treatment with high doses of zidovudine.
Schröder JM; Bertram M; Schnabel R; Pfaff U
Acta Neuropathol; 1992; 85(1):39-47. PubMed ID: 1285495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
